Standardized Medigap Plans

"Standardized Medigap Plans" refers to a set of Medicare Supplement Insurance plans that are standardized by the federal government. Here are the key features of Standardized Medigap Plans:

  • Definition: Standardized Medigap Plans are designed to provide additional coverage to fill the "gaps" in Original Medicare coverage, such as deductibles, copayments, and coinsurance.

  • Plan Options: There are ten standardized Medigap Plans available, labeled A, B, C, D, F, G, K, L, M, and N. The plans are identified by letter, and each plan provides a different set of benefits.

  • Benefits: All Standardized Medigap Plans provide basic benefits, such as coverage for Part A and Part B coinsurance, blood transfusions, and hospice care. Some plans provide additional benefits, such as coverage for Part A and B deductibles, skilled nursing facility care, and foreign travel emergency coverage.

  • Premiums: The premiums for Standardized Medigap Plans vary based on the plan type, location, age, and health status of the individual.

  • Guaranteed Issue Rights: There are certain circumstances, called "guaranteed issue rights," in which individuals can enroll in a Standardized Medigap Plan without being subject to medical underwriting or denial of coverage.

Example:

Jane is enrolled in Original Medicare and wants additional coverage to help pay for her healthcare costs. She decides to enroll in a Standardized Medigap Plan, Plan F. Plan F provides comprehensive coverage, including Part A and Part B deductibles, coinsurance, and copayments, skilled nursing facility care, and foreign travel emergency coverage.Jane pays a monthly premium for her Plan F coverage and can see any doctor who accepts Medicare patients without worrying about additional out-of-pocket costs.

It's important to note that while the benefits of Standardized Medigap Plans are standardized, the premiums vary by insurance company. It's important to compare plan options and premiums carefully before enrolling in a Medigap plan.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.